| 引用本文: | 苏芬丽,沈创鹏,麦美琪,利亭婷,孙旭,蔡庆群.GLP-1受体激动剂超说明书用药情况调查及合理性分析[J].中国现代应用药学,2017,34(11):1611-1615. |
| SU Fenli,SHEN Chuangpeng,MAI Meiqi,LI Tingting,SUN Xu,CAI Qingqun.Investigation and Rationally Analysis of Off-label Drug Use of GLP-1 Receptor Agonist[J].Chin J Mod Appl Pharm(中国现代应用药学),2017,34(11):1611-1615. |
|
| 本文已被：浏览 1899次 下载 1928次 |
码上扫一扫！ |
|
|
| GLP-1受体激动剂超说明书用药情况调查及合理性分析 |
|
苏芬丽1, 沈创鹏2, 麦美琪2,3, 利亭婷1, 孙旭1, 蔡庆群1
|
|
1.广州中医药大学第一附属医院, 药学部, 广州 510405;2.广州中医药大学第一附属医院, 内分泌科, 广州 510405;3.中山市中医院内分泌科, 广东 中山 528400
|
|
| 摘要: |
| 目的 了解GLP-1受体激动剂超说明书用药情况，促进临床合理用药。方法 采用回顾性调查法，抽取内分泌科2015年12月3日-2016年12月14日使用过GLP-1受体激动剂进行治疗的住院病例，按照药品说明书，判断其超说明书用药情况，对超说明书用药进行分类和统计，并评价其合理性。结果 共调查内分泌科住院患者51例，有97例次存在超说明书用药情况，其中超适应证47例次（48.45%），主要表现在联合用药方面，另有50例次（51.55%）属于用法用量超说明书。结论 GLP-1受体激动剂在临床超说明书使用的现象较普遍，某些有其合理性和必要性，但也有不合理用药情况，临床需引起高度重视。 |
| 关键词: GLP-1受体激动剂 超说明书用药 合理用药 |
| DOI：10.13748/j.cnki.issn1007-7693.2017.11.025 |
| 分类号: |
| 基金项目: |
|
| Investigation and Rationally Analysis of Off-label Drug Use of GLP-1 Receptor Agonist |
|
SU Fenli1, SHEN Chuangpeng2, MAI Meiqi2,3, LI Tingting1, SUN Xu1, CAI Qingqun1
|
|
1.First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Pharmacy of Department, Guangzhou 510405, China;2.First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Endocrine Department, Guangzhou 510405, China;3.Endocrine Department, Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan 528400, China
|
| Abstract: |
| OBJECTIVE To investigate the situation of off-label drug use of GLP-1 receptor agonist, so as to promote rational clinical drug use. METHODS By a retrospective survey method, all inpatients in Endocrine Department used GLP-1 receptor agonist from December 3, 2015 to December 14, 2016 were selected, and the situation of off-label drug use was analyzed. RESULTS A total of 51 cases were analyzed, 97 had off-label drug use. The main type of off-label drug use were 47(48.45%) in indications, especially in drug combination, and 50(51.55%) in dose. CONCLUSION The off-label drug use of GLP-1 receptor agonist was common in clinical, and some were reasonable and necessary; yet there were still some irrational phenomenon, which need the close attention by the clinic. |
| Key words: GLP-1 receptor agonist off-label drug use rational drug use |
